KFAS
AGIO icon

Keating Financial Advisory Services’s Agios Pharmaceuticals AGIO Stock Holding History

Keating Financial Advisory Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6K Sell
124
-19
-13% -$576 ﹤0.01% 1594
2026
Q1 		$4.84K Buy
143
+122
+581% +$3.46K ﹤0.01% 1459
2025
Q4 		$572 Buy
+21
New +$737 ﹤0.01% 1924

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Keating Financial Advisory Services's AGIO Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Agios Pharmaceuticals (AGIO) stake by 13% in Q2 2026, selling an estimated $576 and leaving 124 shares worth $4.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

Keating Financial Advisory Services first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.84K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Keating Financial Advisory Services held 124 shares of Agios Pharmaceuticals worth $4.6K as of Q2 2026.
  • Keating Financial Advisory Services sold 19 Agios Pharmaceuticals shares in Q2 2026, an estimated $576.
  • Agios Pharmaceuticals made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1594 holding.
  • Keating Financial Advisory Services first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Agios Pharmaceuticals position peaked at $4.84K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.